EUVIMEDEUVIMED entdecken
Open Access

Activation of δ‐opioid receptors blocks allodynia in a model of headache induced by PACAP

Elizaveta Mangutov, Isaac Dripps, Kendra Siegersma, Yanping Zhang, Rebecca Bocian, Sarah Asif, Timothy Halbesma, Wiktor Witkowski, Amynah A Pradhan iD

British Journal of Pharmacology · 2025-04 · 182 (7) · 1630-1643

DOI: 10.1111/bph.17424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 10.01.2025. Verfasst von Elizaveta Mangutov und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Pharmacology, Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Pituitary Adenylate Cyclase-Activating Polypeptide, Receptors, Opioid, delta, Hyperalgesia, Migraine Disorders. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NIDA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose Pituitary adenylate cyclase activating polypeptide (PACAP) is a human migraine trigger that is being targeted for migraine. The δ‐opioid receptor (δ‐receptor) is a novel target for the treatment of migraine, but its mechanism remains unclear. The goals of this study were to develop a mouse PACAP‐headache model using clinically significant doses of PACAP; determine the effects of δ‐receptor activation in this model; and investigate the co‐expression of δ‐receptors, PACAP and PACAP‐PAC1 receptor. Experimental approach Cephalic allodynia to low doses of acute and chronic PACAP were tested. A triptan (sumatriptan) and a CGRP receptor antagonist (olcegepant) were tested in this model. The δ‐receptor agonist SNC80 was tested in PACAP and CGRP‐induced headache models. Expression of PACAP, PAC1, CRLR and δ‐receptors was determined using in situ hybridisation. Key results Low doses of PACAP produced dose‐dependent acute and chronic cephalic allodynia, blocked by sumatriptan but not by olcegepant. The PAC1 antagonist (M65) did not inhibit CGRP‐induced allodynia. There was moderate co‐expression of PAC1 and CRLR transcripts in migraine‐related regions. SNC80 blocked PACAP‐ and CGRP‐induced allodynia. There was low co‐expression of PACAP and δ‐receptors in brain regions measured. However, there was high co‐expression of PAC1 and δ‐receptors in somatosensory cortex, hippocampus and trigeminal nucleus caudalis. Conclusion and implications We developed a translationally significant model of PACAP‐induced headache, which was mechanistically distinct from CGRP. Activation of δ‐receptors blocked PACAP‐ and CGRP‐induced allodynia, and δ‐receptors were highly co‐expressed with the PACAP‐ergic system. Future studies will examine the functional relationship between δ‐receptors and PAC1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary Adenylate Cyclase-Activating PolypeptideReceptors, Opioid, deltaHyperalgesiaMigraine DisordersAnimalsMaleDisease Models, AnimalMiceMice, Inbred C57BLPiperazinesReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type IAzepinesSumatriptanQuinazolinesCalcitonin Gene-Related Peptide Receptor AntagonistsBenzamides

Stichwörter der Autor:innen

RNAScopeheadacheopioidtrigeminovascular pain

Substanzen

Pituitary Adenylate Cyclase-Activating PolypeptideReceptors, Opioid, delta4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamidePiperazinesReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type IolcegepantAzepinesSumatriptanQuinazolinesCalcitonin Gene-Related Peptide Receptor Antagonists

Autor:innen und Institutionen

  • Center for Clinical Pharmacology, Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, USA.

ORCID-Profile: Amynah A Pradhan

Förderung

  • NIAAA NIH HHS
  • NIDA NIH HHS
  • NINDS NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism
  • National Institute of Neurological Disorders and Stroke
  • National Institute on Drug Abuse

Zitieren

APA

Mangutov, E., Dripps, I., Siegersma, K., Zhang, Y., Bocian, R., Asif, S., Halbesma, T., Witkowski, W., & Pradhan, A. A. (2025). Activation of δ‐opioid receptors blocks allodynia in a model of headache induced by PACAP. British Journal of Pharmacology, 182(7), 1630-1643. https://doi.org/10.1111/bph.17424

Vancouver

Mangutov E, Dripps I, Siegersma K, Zhang Y, Bocian R, Asif S, et al. Activation of δ‐opioid receptors blocks allodynia in a model of headache induced by PACAP. British Journal of Pharmacology. 2025;182(7):1630-1643. doi:10.1111/bph.17424

BibTeX
@article{Mangutov2025,
  author = {Mangutov, Elizaveta and Dripps, Isaac and Siegersma, Kendra and Zhang, Yanping and Bocian, Rebecca and Asif, Sarah and Halbesma, Timothy and Witkowski, Wiktor and Pradhan, Amynah A},
  title = {Activation of δ‐opioid receptors blocks allodynia in a model of headache induced by PACAP},
  journal = {British Journal of Pharmacology},
  year = {2025},
  volume = {182},
  number = {7},
  pages = {1630--1643},
  doi = {10.1111/bph.17424}
}
Kostenlos starten →